Abstract. The effective microorganism (EM-X) fermentation extract is derived from rice bran and seaweed extract. It has been shown to possess anti-oxidation activity both in vitro and in vivo. To our knowledge, the possible in vitro anticancer potential of EM-X has not been demonstrated. Here we showed that the double concentrate of EM-X (EM-X2) at concentrations of 20-30% by volume, had growth inhibitory activity on MDA-MB231 breast cancer cell line and K-562 chronic myelogenous leukaemia cell lines by [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2-H-tetrazolium, inner salt] (MTS) assay. No characteristic features of apoptosis could be observed morphologically. Colony formation assay illustrated that both MDA-MB231 breast cancer and K-562 CML cells lost part of their regeneration potential after treatment with EM-X2 at 30% concentration by volume for 24 h. At these concentrations, only slight growth inhibitory effect was observed in 293 human kidney fibroblast cells and in three non-malignant bone marrows. Intracellular nitro blue tetrazolium (NBT) reduction assay showed that both MDA-MB231 breast cancer and K-562 CML cells had about 30% reduction of intracellular NBT after incubation with 30% of EM-X2. Increased activity of superoxide dismutase (SOD) could be detected from both MDA-MB231 and K-562 cell lines after incubating with 30% of EM-X2. Taken together, our data suggested that EM-X could inhibit growth and reduce the regeneration potential of cancer cells, possibly through its antioxidation activity.
Introduction
Cancer is a leading cause of death. Traditional chemotherapy and radiotherapy have many side effects. There is now great interest in the use of natural products in cancer prevention. A well-recognized example is green tea. It has been demonstrated that green tea extracts and green tea catechins such as (-)-epicatechin and (-)-epigallocatechin have anticancer activities both in vitro and in vivo (1) . Green tea inhibits vascular endothelial growth factor, fibroblast growth factor and tumour angiogenesis (2, 3) . In addition, many plant extracts with antioxidation properties are also found to have anti-cancer properties. Examples include the 70% ethanol extract from the seed of Oenothera biennis L, one of the species of evening primroses. This ethanol extract of evening primroses (EPE) was shown to induce apoptosis in Ehrlich ascites tumour cells (4) .
Effective microorganism fermented extract (EM-X) is a refreshment drink commonly found in East Asia. This is produced by fermentation of papaya, seaweed extract and rice bran using effective microorganisms such as photosynthetic bacteria, lactic acid bacteria and yeast. EM-X is rich in flavonoids, minerals, lycopene, saponin, ubiquinone and ·-tocopherol. It was reported that EM-X significantly reduced tumour nercotic factor · and hydrogen peroxide induced release of interleukin-8 from human alveolar epithelial cell. EM-X also inhibited ascorbic acid and ferric chloride-induced phospholipid liposomal non-enzymatic peroxidation in ox brain in a dose dependent manner (5) . These data showed that the flavonoid-rich EM-X have antioxidant properties (6) and anti-cancer potentials. We studied the possible growth inhibitory activity of EM-X2, the double concentrate of EM-X, on MDA-MB231 breast cancer cells and the K-562 chronic myelogenous leukaemia cells.
Materials and methods
EM-X2 extract. The EM-X2 extract was kindly provided by the EM Research Organization (Okinawa, Japan) in a sterile and liquid form. It was kept at 4˚C in the dark and aliquoted until use.
Cell lines and cell cultures. MDA-MB231 breast cancer cell line, K-562 chronic myeloid leukemia cell line, and the 293 human kidney fibroblast cell line were routinely maintained in RPMI-1640 culture medium (JRH Biosciences) supplemented with 10% fetal bovine serum (Hyclone) in a 5% carbon dioxide incubator with 37˚C (Napco).
Primary bone marrow cultures from non-malignant bone marrow. After informed consent, bone marrow samples were obtained from 3 patients (2 male and 1 female) with nonmalignant haematological disorders. Mononuclear cells were enriched and harvested immediately after Ficoll density centrifugation (Pharmacia L.K.B.) and washed with phosphate buffered saline (PBS), cell pellets were resuspended in RPMI-1640 culture medium and cell viability was determined by Trypan blue exclusion assay as described (7) .
Growth inhibition assay. Changes in the cellular viability of EM-X2 treated cells were monitored using the MTS activity assay as reported previously (8) . Briefly, cells were seeded on day 0 in a 96-well microtiter plate (Yixie from Valency Company). After 24 h of seeding, the culture medium was removed while fresh complete medium with EM-X2 at different concentrations by volume was added. After 48 h of incubation, EM-X2 culture medium was removed and MTS in PBS solution was added. Following 60 min of incubation, optical absorbance at 490 nm was determined (Victor 2 V 1420 multilabel HTS counter, Perkin Elmer, Wallac) according to the user manual provided (Promega).
Intracellular reduction of nitroblue tetrazolium assay. Changes in the intracellular superoxide anion level were reflected by the intracellular nitro blue tetrazolium (NBT) reduction assay. Briefly, cancer cells were seeded on day 0. On day 1, culture medium was removed and the cells were incubated with phenol red-negative RPMI-1640 complete medium containing NBT (1 mg/ml in phosphate buffered saline) and different concentrations of EM-X2. After 48 h, the culture medium was removed and the cancer cells were washed with phosphate buffered saline. The cells were lysed releasing the reduced NBT into the lysis buffer. Optical absorbance was measured. The degree of NBT reduction reflected the intracellular level of superoxide anion.
Morphological monitoring of EM-X2 treated cells.
After EM-X2 treatment, morphological changes and intracellular reduction of NBT from EM-X2 treated cells were monitered by examinations under an inverted microscope (Nikon).
Measurement of superoxide dismutase activity. Briefly, after 48 h of EM-X2 treatment, cells were washed with phosphate buffered saline and then resuspended in lysis buffer. Afterwards, cellular extract was divided into two parts. One part was mixed with xanthine buffered solution containing xanthine and xanthine oxidase. Then NBT solution was added and they were incubated for a further 15 min. The reaction was terminated by adding sodium dodecyl sulfate solution. The optical absorbance was then determined and recorded. The remaining cellular extract was used for protein standardization using the Bradford method (Bio-Rad). Finally, the result of superoxide dismutase activity in terms of arbitrary unit was normalized with cellular protein content and compared with the untreated control.
Colony formation assay. The cancer cell lines MDA-MB231 and K-562 were incubated with various concentrations of EM-X2 for 24 h. The cells were then harvested, washed, stained with Trypan blue and counted. For MDA-MB231 breast cancer cells, they were cultured in completed RPMI-1640 medium while K-562 CML cells were cultured in methylcellulose semi-solid medium (Stem Cell Technology, Canada). Cells were incubated for 7-14 days. For MDA-MB231 cells, they were stained with methylene blue and then counted. For K-562 cells, they were directly counted under an inverted microscope (Nikon).
Results

Growth inhibitory activity of EM-X2 on MDA-MB231 and K-562 cancer cells.
After 48 h incubation, we observed that EM-X2 inhibited the growth of both MDA-MB231 breast cancer cell and K-562 CML cell in a dose-dependent manner at 10-30% concentrations by volume (Fig. 1A) using the MTS activity assay. However, characteristic feature of apoptosis such as cell shrinkage could not be detected in either cancer cell line (Fig. 2) . At these EM-X2 concentrations, only slight growth inhibitory activity was detected on 293 human kidney fibroblasts and non-malignant bone marrow cells (Fig. 1B) . We have tested whether there was any direct redox reaction between the EM-X2 and MTS. The results were negative, showing that the changes in MTS from yellowish green to brown was due to the enzymatic activity which reflected the viability of cells. There was no significant change in the physical property (e.g. pH value) of culture medium after diluting with EM-X2.
Intracellular reduction of nitroblue tetrazolium assay. Both MBA-MB231 breast cancer cells and K-562 CML cells showed significant decrement in intracellular NBT reduction after 48 h of incubation with EM-X2 at 30% concentration by volume. We noticed that the decrement of intracellular NBT reduction was almost even among cell population when compared with untreated control. Thus the result was not due to the difference in cell number. Representative results are shown in Fig. 2 . No direct chemical reaction was found between EM-X2 and NBT. Interestingly, the NBT reduction activity in the human kidney fibroblast 293 was not significantly affected by EM-X2 treatment (Fig. 3) .
Changes of intracellular superoxide dismutase activity. After EM-X2 treatment, any change in the intracellular superoxide dismutase activity was determined in the form of its lysed cellular extract. Under normal physiological condition, superoxide dismutase catalyzes the conversion of superoxide anion to hydrogen peroxide and molecular oxygen. The relative activity of intracellular superoxide dismutase was increased about 10-15% when compared with untreated control after 48 h of 30% of EM-X2 incubation (Fig. 4, upper) .
EM-X2 reduced the regeneration potentials of cancer cells.
After incubating with 30% of EM-X2, both MBA-MB231 breast cancer and K562 leukaemia cells showed a reduction in colony formations by anchorage dependent assay and semi-solid medium colony formation assay respectively (Fig. 4, B) .
Discussion
EM-X is a refreshment drink in Japan and it can be mixed with coffee or tea during consumption. Recently, the antioxidation property of EM-X has been demonstrated in vitro (5) and in vivo (9) . Aruoma et al showed that oral administration of EM-X to rats for seven days inhibited ferric-nitrilotriacetic acid (Fe-NAT)-dependent oxidation of fatty acids while docosapentanenoic, docosahexanoic, oleic, arachidonic, eicosadieonoic and linoleic acids were protected in the kidneys and liver. As ·-tocopherol and glutathione levels were mainly unaffected, the EM-X effect was mainly due to the in vivo inhibition of lipid peroxidation. This is likely mediated by the bioactive flavonoids in EM-X (9). In addition, EM-X was shown to protect the retinal neurons in rats from the excitotoxicity of the glutamate agonist, N-methyl-D-aspartate (10) . These antioxidant activities of EM-X might have anticancer potentials.
We first showed that EM-X2 had growth inhibition activity on MDA-MB231 and K-562 cell lines. The degree of growth inhibition was dose dependent in the tested EM-X2 concentrations of 10% to 30% by volume. We also observed that only slight growth inhibition could be detected in 293 human kidney fibroblast and bone marrow cells patients with non-malignant haematological disorders. The dose of EM-X2 which could inhibit the growth of both MDA-MB231 and K-562 cancer cells, had little toxicity on normal fibroblast and bone marrow cells. Since no characteristic features of apoptosis were observed, it was possible that the cancer cells were arrested at certain phase(s) of cell cycle rather than going to the sub-G1/G0 apoptotic phase. Colony formation potency of both cancer cell lines was reduced with EM-X2, which also supported the above postulate.
A hypothesis has been put forward that the inhibition of tumour cell growth can be attributed to the increase in the steady state levels of hydrogen peroxide as a result of the increased dismuting activity of manganese superoxide dismutase (11) . The EM-X fermentation extract contains components derived from plants such as saponin, flavonoid, Á-olizanol and it is rich in various types of vitamins. The above ingredients could directly eliminate free radicals, or increases the activity of superoxide dismutase by electrons transfer (12) . As anticipated, EM-X2 could decrease intracellular NBT reduction and simultaneously increase superoxide dismutase activity. We speculated that the antioxidation property of EM-X2 could play an important role on the growth inhibition of both MDA-MB231 and K-562 cancer cells. Whether other possible mechanisms are involved would require further investigation.
In conclusion, our results suggested that the EM-X fermentation extract might have anti-cancer potential. Recently, we have shown that the fruit extract of Gleditsia sinensis, a traditional Chinese medicine, also has antiangiogenic activity (13) . We also discovered that both basic fibroblast growth factor and nitric oxide might be involved in the Gleditsia sinensis fruit extract induced growth inhibition (14) . Currently, we are studying the possible antiangiogenic potential of EM-X on human umbilical cord blood endothelial cell model (15) . Nude mice xenograft experiments should be carried out to investigate the possible anticancer activity of EM-X in an animal model. Since EM-X is a common refreshment drink, whether it could exert chemoprevention effects is of particular interest.
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